Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 May 1;175(5):1301-5.
doi: 10.1084/jem.175.5.1301.

Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1

Affiliations

Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1

N S Braunstein et al. J Exp Med. .

Abstract

Class II major histocompatibility complex (MHC) molecules present peptides derived from processed antigen to antigen-specific CD4-positive T cells. In addition, class II molecules bind with high affinity another class of antigens, termed superantigens. T cell stimulation by superantigens depends almost exclusively on the V beta segment expressed by the T cell receptor (TCR). Mapping of the superantigen binding site on class II molecules should provide valuable information on how MHC and TCR molecules interact. Recombinant mouse I-A class II molecules expressed on transfected L cells were analyzed for their ability to bind the toxic shock syndrome toxin 1. Polymorphic residues in the alpha helices of both the alpha and beta chains of I-A contributed to quantitative toxin binding, suggesting that the toxin binds to either a combinatorial or a conformational site on class II MHC molecules.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Curr Top Microbiol Immunol. 1978;81:115-20 - PubMed
    1. J Exp Med. 1992 Feb 1;175(2):415-24 - PubMed
    1. J Immunol. 1990 Sep 15;145(6):1635-45 - PubMed
    1. J Immunol. 1991 Dec 1;147(11):3876-81 - PubMed
    1. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9954-8 - PubMed

Publication types